These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 3008052

  • 1. Role of Ca 125 as tumor marker in ovarian carcinoma.
    Krebs HB, Goplerud DR, Kilpatrick SJ, Myers MB, Hunt A.
    Obstet Gynecol; 1986 Apr; 67(4):473-7. PubMed ID: 3008052
    [Abstract] [Full Text] [Related]

  • 2. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
    Kivinen S, Kuoppala T, Leppilampi M, Vuori J, Kauppila A.
    Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
    [Abstract] [Full Text] [Related]

  • 3. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
    Schröck R, Hafter R, Schmid L, Babic R, Ulm K, Gössner W, Graeff H.
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
    [Abstract] [Full Text] [Related]

  • 4. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y, Fujiwara H, Akagaki E, Hirota K, Kono M, Irie T, Miura S, Okudaira Y.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [Abstract] [Full Text] [Related]

  • 5. [Tumor markers in gynecologic diseases].
    Geyer H, Kleine W.
    Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):168-72. PubMed ID: 3472991
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous measurement of CA 125, CA 19-9, tissue polypeptide antigen, and immunosuppressive acidic protein to predict recurrence of ovarian cancer.
    Kamiya N, Mizuno K, Kawai M, Kano T, Furuhashi Y, Tomoda Y.
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):417-21. PubMed ID: 2381619
    [Abstract] [Full Text] [Related]

  • 7. CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancer.
    Gadducci A, Ferdeghini M, Prontera C, Moretti L, Pellagatta L, Bianchi R, Fioretti P.
    J Nucl Biol Med (1991); 1991 Sep; 35(1):33-7. PubMed ID: 1657201
    [Abstract] [Full Text] [Related]

  • 8. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
    Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Knapp RC.
    N Engl J Med; 1983 Oct 13; 309(15):883-7. PubMed ID: 6310399
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
    Crombach G, Zippel HH, Würz H.
    Geburtshilfe Frauenheilkd; 1985 Apr 13; 45(4):205-12. PubMed ID: 2408962
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses.
    Chen DX, Schwartz PE, Li XG, Yang Z.
    Obstet Gynecol; 1988 Jul 13; 72(1):23-7. PubMed ID: 3164105
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y, Akagaki E, Hirota K, Kono M, Miura S, Okudaira Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec 13; 37(12):2813-20. PubMed ID: 3866801
    [Abstract] [Full Text] [Related]

  • 17. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y, Furuno K, Sano Y, Hirata T, Utsunomiya A, Nakajima H, Okabe K, Shimizu K, Akiya K, Fujiwara Y.
    Gan No Rinsho; 1985 May 13; 31(6 Suppl):655-63. PubMed ID: 2993692
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U, Baumgartner L, Stieber P, Meier W, Hofmann K, Fateh-Moghadam A.
    Anticancer Res; 1994 May 13; 14(6B):2743-6. PubMed ID: 7532929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.